Zacks • 7 days ago
The likely revocation of the 2.3% medical device excise tax is going to be a big bonus for both the behemoths and small players.
Moody's • 11 days agoGrifols World Wide Operations Ltd. -- Moody's assigns Ba2 to Grifols' new term loans and revolver; Ba3 CFR unchanged
London, 13 January 2017-- Moody's Investors Service has today assigned a Ba2 rating to the proposed USD4.425 billion senior secured bank credit facilities to be issued by Grifols World Wide Operations ...
Investopedia • 14 days ago
Hologic, which recently sold a “non-core” business division for $1.85 billion, was slated to present Tuesday at the J.P. Morgan Healthcare Conference.
Investor's Business Daily • last month
Hologic sold its declining blood screening venture to partner Grifols. The $1.8 billion price was "lofty" according to a Canaccord analyst.
CNBC Videos • last month
David Sowerby, Loomis Sayles & Co. vice president & portfolio manager, and Michael Vogelzang, Boston Advisors president and CIO, give their best picks for next year as well as which names investors should stay away from.
HOLX : Summary for Hologic, Inc. - Yahoo Finance
Hologic, Inc. (HOLX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||39.00 x 100|
|Day's Range||39.17 - 39.56|
|52 Week Range||31.84 - 41.01|
|PE Ratio (TTM)||87.24|
|Earnings Date||Feb 1, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||45.00|